Lantern Pharma (LTRN) Financials

$1.85

$-0.02 (-1.07%)

As on 04-Sep-2026 13:30EDT

Market cap

$26 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

9.7

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Operating Revenue	--	--	--	--	--	--
Cost of Revenue	0.00	0.02	0.19	0.17	0.15	0.10
Gross Profit	0.00	-0.02	-0.19	-0.17	-0.15	-0.10
Operating Expenses	15.46	17.98	22.22	17.70	14,432.75	12.59
Operating Profit (EBIT)	-15.47	-17.98	-22.22	-17.88	-14,432.75	-12.59
Other Income	--	--	--	--	--	--
Profit before Tax	-18.65	-17.12	-20.78	-15.96	-14,259.95	-12.36
Provision for Tax	--	--	--	0.00	-0.17	-0.07
Profit after Tax (Net Income)	-18.65	-17.12	-20.78	-15.96	-14,259.95	-12.36
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	-14.26	-12.36

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Shareholder's Funds	-3.22	6.53	21.19	40.91	56.04	71.57
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	7.50	0.00	0.05	0.06	--	0.05
Current Liabilities	4.32	4.50	4.33	2.68	2.80	2.33
Total Liabilities	12.92	11.04	25.57	43.65	58.84	73.95

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Non-Current Assets	0.14	0.23	0.32	0.31	0.11	1.23
Current Assets	8.46	10.80	25.25	43.34	58.72	72.72
Total Assets	17.06	11.04	25.57	43.65	58.84	73.95
Total Debt*	0.04	78.54	0.24	0.23	0.05	0.20
Net Current Assets	--	6.30	20.92	40.66	55.92	70.39

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	-15.68	-17.81	-14.35	-12.77	-10.59
Cash Flow from Investing Activities	--	11.06	3.37	-0.93	0.18	-19.53
Cash from Financing Activities	--	1.50	0.07	-0.50	-2.18	63.42
Net Cash Inflow / Outflow	--	--	--	--	-14.77	--

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	-1.62	-1.57	-1.93	-1.48	-1,313.82	-1.11
Cash EPS ($)	--	-1.57	-1.93	-1.48	-1,313.82	-1.10
Adjusted Book Value ($)	--	0.60	1.96	3.79	5.16	6.40
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-1.44	-1.65	-1.33	-1.18	-0.95
Free Cash Flow per Share ($)	--	-1.44	-1.65	-1.33	-1.18	-0.95

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	-32.15	-66.42	-32.83	-22,304.29	-27.00
ROE (%)	--	-123.51	-66.93	-32.93	-22,349.36	-27.09
ROA (%)	-94.77	-93.53	-60.04	-31.15	-21,477.96	-26.22
EBIT Margin (%)	--	--	--	--	--	--
Net Margin (%)	--	--	--	--	--	--
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	--	--	--	--	--	--
EBIT Growth (%)	3.10	17.62	-30.20	-13.56	-13.69	-109.25
Net Profit Growth (%)	3.10	17.62	-30.20	99.89	-115,243.46	-109.25
EPS Growth (%)	9.02	0.18	-0.30	1.00	-1,187.77	-0.16
Book Value Growth (%)	-122.30	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	--	-1.93	-1.66	-2.90	0.00	-7.22
Price / Book Value	9.74	5.05	1.62	1.13	1.17	1.25
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	0.21	-5.93	-0.51	-0.33	0.00	-1.52
Close Price ($)	4.17	3.03	3.19	4.28	6.04	7.98
High Price ($)	5.74	6.12	11.99	6.20	8.30	23.50
Low Price ($)	1.11	2.55	2.79	2.38	4.19	7.01
Market Cap ($ Cr)	26.46	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	--	12.02	0.01	0.01	0.00	0.00
Short term debt to equity ratio	-0.01	12.02	0.01	0.00	0.00	0.00
Current Ratio	1.96	2.40	5.83	16.18	20.99	31.26
Quick Ratio	1.96	--	--	--	21.20	31.34
Interest Coverage	--	--	--	--	-68.78	-55.76

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	--	--	--	--	--	--
Asset Turnover	--	--	--	--	--	--
Receivable days	--	--	--	--	--	--
Inventory Days	--	--	--	-1,236.70	-912.65	-678.60
Payable days	--	90,503.04	4,872.64	1,958.05	3,667.73	4,886.04
Cash Conversion Cycle	--	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.